RNCOS has recently added a new Market Research Report titled, “Global API Market Analysis” to its report gallery. After witnessing a slump in demand and manufacturing index due to after-impact of economic recession, the global API market has been advancing at a significant growth rate in recent times. The market, which is likely to register a healthy CAGR of around 8% during 2012-2015, is supported by various key factors, such as emergence of India and China as prominent API manufacturing hub, patent expiration of blockbuster drugs and technological innovation to drive HPAPI segment. Further, impressive participation of private players is positively boosting the API production.
As per our report, “Global API Market Analysis”, the focus of global pharmaceutical and biotech industry participants is shifting towards cost-effective and quality-driven destinations, such as India and China. These countries provide cheap labor, high productivity, low-investment to set-up plant, good profit margins, among others. In addition, there is a set of supportive regulations that support the local manufacturing and at the same time encourage export between nations. With regards to liberal competitive scenario in India and China, the report has effectively provided a comparative analysis among countries with respect to key indicators, such as labor cost and productivity, price structure, and investment cost to set up plant.
It is worthy to mention here that the report takes into account those countries that are likely to provide profitable market opportunities for API market participants. In other words, the overall study analyzes the current and future outlook of API exporting nations, such as India, China and Italy. As our study shows that many countries in the world deal with API import or manufacture less number of APIs, we have not covered them.
Our study indicates that High Potency Active Pharmaceutical Ingredients (HPAPIs) is expected to play a major role in the future growth of global APIs market. With a worldwide value of US$ 9.2 Billion in 2011, the HPAPI market is growing at a CAGR of around 9% till 2015. Growth in the oncology therapeutics market will primarily drive the market. The report, in such a context, covers an in-depth study of global HPAPI market and bifurcate the segment by synthesis agent, branded and generics. In addition, it also elucidates the key developments with regards to HPAPIs in order to provide a comprehensive analysis.
The report provides an extensive research and prudent analysis on the worldwide API market and illustrates the industry segment into significant manner. Separate sections on therapeutic-wise analysis and emerging opportunities from High Potency APIs has also been covered separately in the report. Moreover, it provides an overview of the regulatory environment. The research contains exhaustive information on the market players, recent developments and geographical markets that will help clients in formulating market strategies and assess opportunity areas in the global APIs market.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM320.htm
Some of our Related Reports are:
- Global Telemedicine Market Analysis (http://www.rncos.com/Report/IM331.htm)
- Personalized Medicine Market Analysis (http://www.rncos.com/Report/IM305.htm)
- Global Regenerative Medicine Market (http://www.rncos.com/Report/IM363.htm)
- Emerging Pharmaceutical Markets Globally
- Booming Clinical Trials Market in India (http://www.rncos.com/Report/IM564.htm)
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.